C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation
Mycobacterium tuberculosis requires the enzyme isocitrate lyase (ICL) for growth and virulence in vivo. The demonstration that M. tuberculosis also requires ICL for survival during nutrient starvation and has a role during steady state growth in a glycerol limited chemostat indicates a function for this enzyme which extends beyond fat metabolism. As isocitrate lyase is a potential drug target elucidating the role of this enzyme is of importance; however, the role of isocitrate lyase has never been investigated at the level of in vivo fluxes. Here we show that deletion of one of the two icl genes impairs the replication of Mycobacterium bovis BCG at slow growth rate in a carbon limited chemostat. In order to further understand the role of isocitrate lyase in the central metabolism of mycobacteria the effect of growth rate on the in vivo fluxes was studied for the first time using 13C-metabolic flux analysis (MFA). Tracer experiments were performed with steady state chemostat cultures of BCG or M. tuberculosis supplied with 13C labeled glycerol or sodium bicarbonate. Through measurements of the 13C isotopomer labeling patterns in protein-derived amino acids and enzymatic activity assays we have identified the activity of a novel pathway for pyruvate dissimilation. We named this the GAS pathway because it utilizes the Glyoxylate shunt and Anapleurotic reactions for oxidation of pyruvate, and Succinyl CoA synthetase for the generation of succinyl CoA combined with a very low flux through the succinate – oxaloacetate segment of the tricarboxylic acid cycle. We confirm that M. tuberculosis can fix carbon from CO2 into biomass. As the human host is abundant in CO2 this finding requires further investigation in vivo as CO2 fixation may provide a point of vulnerability that could be targeted with novel drugs. This study also provides a platform for further studies into the metabolism of M. tuberculosis using 13C-MFA.
Vyšlo v časopise:
C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002091
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002091
Souhrn
Mycobacterium tuberculosis requires the enzyme isocitrate lyase (ICL) for growth and virulence in vivo. The demonstration that M. tuberculosis also requires ICL for survival during nutrient starvation and has a role during steady state growth in a glycerol limited chemostat indicates a function for this enzyme which extends beyond fat metabolism. As isocitrate lyase is a potential drug target elucidating the role of this enzyme is of importance; however, the role of isocitrate lyase has never been investigated at the level of in vivo fluxes. Here we show that deletion of one of the two icl genes impairs the replication of Mycobacterium bovis BCG at slow growth rate in a carbon limited chemostat. In order to further understand the role of isocitrate lyase in the central metabolism of mycobacteria the effect of growth rate on the in vivo fluxes was studied for the first time using 13C-metabolic flux analysis (MFA). Tracer experiments were performed with steady state chemostat cultures of BCG or M. tuberculosis supplied with 13C labeled glycerol or sodium bicarbonate. Through measurements of the 13C isotopomer labeling patterns in protein-derived amino acids and enzymatic activity assays we have identified the activity of a novel pathway for pyruvate dissimilation. We named this the GAS pathway because it utilizes the Glyoxylate shunt and Anapleurotic reactions for oxidation of pyruvate, and Succinyl CoA synthetase for the generation of succinyl CoA combined with a very low flux through the succinate – oxaloacetate segment of the tricarboxylic acid cycle. We confirm that M. tuberculosis can fix carbon from CO2 into biomass. As the human host is abundant in CO2 this finding requires further investigation in vivo as CO2 fixation may provide a point of vulnerability that could be targeted with novel drugs. This study also provides a platform for further studies into the metabolism of M. tuberculosis using 13C-MFA.
Zdroje
1. BesteDJVPetersJHooperTAvignone-RossaCBushellME 2005 Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism. J Bacteriol 187 1677 1684
2. BesteDJVHooperTStewartGBondeBAvignone-RossaC 2007 GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol 8 R89
3. BesteDJVLaingEBondeBAvignone-RossaCBushellME 2007 Transcriptomic analysis identifies growth rate modulation as a component of the adaptation of mycobacteria to survival inside the macrophage. J Bacteriol 189 3969 3976
4. BesteDJVEspasaMBondeBKierzekAMStewartGR 2009 The genetic requirements for fast and slow growth in mycobacteria. PLoS ONE 4 e5349
5. McKinneyJDHonerzMunozEMiczakAChenB 2000 Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406 735 738
6. Munoz-EliasEJMcKinneyJD 2005 Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11 638 644
7. LorenzMCFinkGR 2001 The glyoxylate cycle is required for fungal virulence. Nature 412 83 86
8. LyeYMChanMSimTS 2005 Endorsing functionality of Burkholderia pseudomallei glyoxylate cycle genes as anti-persistence drug screens. J Mol Catal B: Enzymatic 33 51 56
9. Munoz-EliasEJUptonAMCherianJMcKinneyJD 2006 Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Micro 60 1109 1122
10. GengenbacherMRaoSPSPetheKDickT 2010 Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156 81 87
11. BaughnADGarforthSJVilchzeCJacobsWR 2009 An anaerobic-type α-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis. PLoS Pathog 5 e1000662
12. LiuZWangQZhaoX 2008 Metabolic flux analysis of yfiD gene knockout Escherichia coli based on 13C-labeling experiments under anaerobic conditions. J Biotech 136 S34
13. DaunerMStorniTSauerU 2001 Bacillus subtilis metabolism and energetics in carbon-limited and excess-carbon chemostat culture. J Bacteriol 183 7308 7317
14. BentrupKHZMiczakASwensonDLRussellDG 1999 Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J Bacteriol 181 7161 7167
15. GarnierTEiglmeierKCamusJCMedinaNMansoorH 2003 The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100 7877 7882
16. WayneLGLinKY 1982 Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun 37 1042 1049
17. SeshadriRSuryanarayanaMVenkitasubramanianTA 1978 Role of malic enzyme in mycobacteria: Part I–Malic enzyme & its relationship to growth rate & intracellular level of NADPH. Indian J Biochem Biophys 15 277 281
18. WiechertWMollneyMPetersenSrde GraafAA 2001 A universal framework for 13C metabolic flux analysis. Met Eng 3 265 283
19. TianJBrykRItohMSuematsuMNathanC 2005 Variant tricarboxylic acid cycle in Mycobacterium tuberculosis: Identification of α-ketoglutarate decarboxylase. Proc Natl Acad Sci USA 102 10670 10675
20. de CarvalhoLPZhaoHDickinsonCEArangoNMLimaCD 2010 Activity-based metabolomic profiling of enzymatic function: Identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase. Chem Biol 17 323 332
21. Prasad MaharjanRYuPLSeetoSFerenciT 2005 The role of isocitrate lyase and the glyoxylate cycle in Escherichia coli growing under glucose limitation. Res Micro 156 178 183
22. FischerESauerU 2003 A novel metabolic cycle catalyzes glucose oxidation and anaplerosis in hungry Escherichia coli. J Biol Chem 278 46446 46451
23. MarreroJRheeKYSchnappingerDPetheKEhrtS 2010 Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci USA 107 9819 9824
24. ZamboniNMaaheimoHSzyperskiTHohmannHPSauerU 2004 The phosphoenolpyruvate carboxykinase also catalyzes C3 carboxylation at the interface of glycolysis and the TCA cycle of Bacillus subtilis. Metab Eng 6 277 284
25. MukhopadhyayBPurwantiniE 2000 Pyruvate carboxylase from Mycobacterium smegmatis: stabilization, rapid purification, molecular and biochemical characterization and regulation of the cellular level. Biochim Biophys Acta 1475 191 206
26. SassettiCMBoydDHRubinEJ 2003 Genes required for mycobacterial growth defined by high density mutagenesis. Mol Micro 48 77 84
27. Peters-WendischPGWendischVFPaulSEikmannsBJSahmH 1997 Pyruvate carboxylase as an anaplerotic enzyme in Corynebacterium glutamicum. Microbiology 143 1095 1103
28. SchaeferWBCohnMLMiddlebrookG 1955 The roles of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol 69 706 712
29. NishiharaH 1954 Studies on the metabolism of the tubercule bacillus with the use of radioactive substrates in the presence and absence of streptomycin. J Biochem 41 167 181
30. LongERAndersonRJRittenbergDKarnovskyMLHendersonHJ 1955 The carbon metabolism of the tubercule bacillus. Am Rev Tuberc 71 609 615
31. FlorczykMAMcCueLAPurkayasthaACurrentiEWolinMJ 2003 A family of acr-coregulated Mycobacterium tuberculosis genes shares a common DNA motif and requires rv3133c (dosR or devR) for expression. Infect Immun 71 5332 5343
32. RengarajanJBloomBRRubinEJ 2005 Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 102 8327 8332
33. BettsJCLukeyPTRobbLCMcAdamRADuncanK 2002 Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43 717 731
34. ParkSWHwangEHParkHKimJAHeoJ 2003 Growth of mycobacteria on carbon monoxide and methanol. J Bacteriol 185 142 147
35. ColeSTBroschRParkhillJGarnierTChurcherC 1998 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 537 544
36. SrinivasanVMorowitzHJ 2006 Ancient genes in contemporary persistent microbial pathogens. Biol Bull 210 1 9
37. GouldingCWBowersPMSegelkeBLekinTKimCY 2007 The structure and computational analysis of Mycobacterium tuberculosis protein CitE suggest a novel enzymatic function. J Mol Biol 365 275 283
38. FregnanGBSmithDWRandallHM 1961 Biological and chemical studies on mycobacteria: Relationship of colony morphology to mycoside content for Mycobacterium kansasii and Mycobacterium fortuitum. J Bacteriol 82 517 527
39. LynchHCBushellME 1995 The physiology of erythromycin biosynthesis in cyclic fed batch culture. Microbiology 141 3105 3111
40. SambrookJFritschEFManiatisT 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York Cold Spring Harbor Laboratory Press
41. ParishTStokerNG 2000 Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146 1969 1975
42. MukhopadhyayBConcarEMWolfeRS 2001 A GTP-dependent vertebrate-type phosphoenolpyruvate carboxykinase from Mycobacterium smegmatis. J Biol Chem 276 16137 16145
43. GourdonPBaucherMFLindleyNDGuyonvarchA 2000 Cloning of the malic enzyme gene from Corynebacterium glutamicum and role of the enzyme in lactate metabolism. Appl Environ Microbiol 66 2981 2987
44. SeshadriRSuryanarayanaMVenkitasubramanianTA 1978 Role of malic enzyme in mycobacteria: Part II–Purification & properties of malic enzyme from Mycobacterium smegmatis. Indian J Biochem Biophys 15 282 285
45. WayneLGHayesLG 1996 An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64 2062 2069
46. BorodinaISiebringJZhangJSmithCPvan KeulenG 2008 Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion. J Biol Chem: 283 25186 25199
47. LowryOHRosebroughNJFarrALRandallRJ 1951 Protein measurement with the folin phenol reagent. J Biol Chem 193 265 276
48. WiechertWSiefkeCde GraafAAMarxA 1997 Bidirectional reaction steps in metabolic networks: II. Flux estimation and statistical analysis. Biotechnol Bioeng 55 118 135
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requires Glycerol for Maximum Fitness During The Tick Phase of the Enzootic Cycle
- Comparative Genomics Yields Insights into Niche Adaptation of Plant Vascular Wilt Pathogens
- The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations
- “Persisters”: Survival at the Cellular Level